Straits Times Index
3,220.59 +18.70 (+0.58%) Nikkei
26,831.32 +171.57 (+0.64%) Hang Seng
20,413.76 -188.76 (-0.92%) FTSE 100
7,518.35 +53.55 (+0.72%) BTC-USD
30,185.45 +244.43 (+0.82%) CMC Crypto 200
679.19 +436.51 (+179.87%)
Aditxt, Inc. (ADTX)
After hours:
| Previous close | 0.2950 |
| Open | 0.2901 |
| Bid | 0.2729 x 800 |
| Ask | 0.2730 x 1400 |
| Day's range | 0.2451 - 0.3229 |
| 52-week range | 0.2410 - 3.9500 |
| Volume | |
| Avg. volume | 627,553 |
| Market cap | 12.031M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4290 |
| Earnings date | 13 Nov 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.00 |
- Business Wire
Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accelerate Adoption and Revenue Growth
RICHMOND, Va., April 14, 2022--Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX), a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, today is announcing a multiyear partnership with GRS, an affiliate of marketing powerhouse Guthy-Renker, LLC ("Guthy-Renker"). This partnership will focus on building awareness and visibility among consumers and healthcare providers for the AditxtScore™ Immune Monitoring Platform. Aditxt plans to work
- Business Wire
Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th
RICHMOND, Va., April 05, 2022--Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX) has entered into a revenue-sharing agreement with Cellvera, and certain of its affiliates. The agreement is designed to drive strategic revenue and growth starting in 2022 and provide enhanced security for the Company’s $14.5 million loan, plus interest to Cellvera Global Holdings LLC ("Cellvera"), formerly AiPharma Global Holdings LLC. The Company has signed the agreement as consideration for Aditxt’s separa
- Business Wire
Aditxt to Participate in the 2022 Virtual Growth Conference
RICHMOND, Va., March 23, 2022--Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, announced today that Company CEO & Co-Founder, Amro Albanna, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.
